Cost-effectiveness of tenofovir gel in urban South Africa: model projections of HIV impact and threshold product prices.

Terris-Prestholt, F; Foss, AM; Cox, AP; Heise, L; Meyer-Rath, G; Delany-Moretlwe, S; Mertenskoetter, T; Rees, H; Vickerman, P; Watts, CH; (2014) Cost-effectiveness of tenofovir gel in urban South Africa: model projections of HIV impact and threshold product prices. BMC infectious diseases, 14 (1). p. 14. ISSN 1471-2334 DOI: https://doi.org/10.1186/1471-2334-14-14

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1186/1471-2334-14-14

Abstract

Share

Download

Filename: 1471-2334-14-14.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar